Viome is a team of leading entrepreneurs, scientists, and physicians. Our proven expertise is why Viome is the only private company trusted with exclusive license to technology first developed at the prestigious Los Alamos National Laboratory.
MICROBIOME FOCUSED WELLNESS TECHNOLOGY AIMING TO MAKE ILLNESS OPTIONAL!
Viome is focused on disrupting healthcare by “making illness optional”. The Viome test is a breakthrough microbiome bacteria, epigenetics, epigenome and epigenomics technology.
Chronic diseases are the fastest growing diseases all over the world. Viome has the potential to positively impact millions of people if not billions all around the world. Driven to create a future where illness is optional by identifying predictive biomarkers for diseases before any symptoms may occur so they can be prevented. The goal is to responsibly present facts in a way that can help anyone make decision. By applying Artificial Intelligence to the massive amount of high resolution microbiome and genetic data to find predictive biomarkers for chronic diseases. Viome’s state-of-the-art proprietary technologies offer unprecedented visibility into ecosystem of our body to create a unique molecular profile.